{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:14:43Z","timestamp":1778235283778,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFB3804504"],"award-info":[{"award-number":["2022YFB3804504"]}]},{"name":"National Natural Science Foundation of China, Youth Project","award":["Nos. 82101838, 82203367, 82203505, and 82203403"],"award-info":[{"award-number":["Nos. 82101838, 82203367, 82203505, and 82203403"]}]},{"name":"Experimental Animal Fund of Shanghai Science and Technology Commission","award":["No. 22140903800"],"award-info":[{"award-number":["No. 22140903800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10677-9","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T17:14:37Z","timestamp":1752513277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CENPF overexpression in bladder cancer cells enhances proliferation, migration, invasion, and apoptosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Ruixiang","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhensheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinshan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxiong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"10677_CR1","doi-asserted-by":"publisher","unstructured":"Sanguedolce, F. et al. HER2 expression in bladder cancer: a focused view on its diagnostic, prognostic, and predictive role. Int. J. Mol. Sci. 24, 145. https:\/\/doi.org\/10.3390\/ijms24043720 (2023).","DOI":"10.3390\/ijms24043720"},{"key":"10677_CR2","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1186\/s12885-021-08611-z","volume":"21","author":"J Li","year":"2021","unstructured":"Li, J. et al. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. BMC Cancer. 21, 858. https:\/\/doi.org\/10.1186\/s12885-021-08611-z (2021).","journal-title":"BMC Cancer"},{"key":"10677_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.23736\/s2724-6051.22.04953-9","volume":"75","author":"R Contieri","year":"2023","unstructured":"Contieri, R. et al. Accuracy of the European association of urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG. Minerva Urol. Nephrol. 75, 180\u2013187. https:\/\/doi.org\/10.23736\/s2724-6051.22.04953-9 (2023).","journal-title":"Minerva Urol. Nephrol."},{"key":"10677_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk, M. et al. European association of urology guidelines on Non-muscle-invasive bladder Cancer (Ta, T1, and carcinoma in Situ). Eur. Urol. 81, 75\u201394. https:\/\/doi.org\/10.1016\/j.eururo.2021.08.010 (2022).","journal-title":"Eur. Urol."},{"key":"10677_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.eururo.2021.09.026","volume":"81","author":"R Cathomas","year":"2022","unstructured":"Cathomas, R. et al. The 2021 updated European association of urology guidelines on metastatic urothelial carcinoma. Eur. Urol. 81, 95\u2013103. https:\/\/doi.org\/10.1016\/j.eururo.2021.09.026 (2022).","journal-title":"Eur. Urol."},{"key":"10677_CR6","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/s0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat, E. et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet 400, 1712\u20131721. https:\/\/doi.org\/10.1016\/s0140-6736(22)01188-6 (2022).","journal-title":"Lancet"},{"key":"10677_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.32074\/1591-951x-838","volume":"115","author":"MR Raspollini","year":"2022","unstructured":"Raspollini, M. R. et al. News in the classification of WHO 2022 bladder tumors. Pathologica 115, 32\u201340. https:\/\/doi.org\/10.32074\/1591-951x-838 (2022).","journal-title":"Pathologica"},{"key":"10677_CR8","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1038\/s41598-017-02990-9","volume":"7","author":"S Zeng","year":"2017","unstructured":"Zeng, S. et al. Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma. Sci. Rep. 7, 3151. https:\/\/doi.org\/10.1038\/s41598-017-02990-9 (2017).","journal-title":"Sci. Rep."},{"key":"10677_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1053\/j.gastro.2012.06.007","volume":"143","author":"S Ma","year":"2012","unstructured":"Ma, S. et al. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma. Gastroenterology 143, 675\u2013686e612. https:\/\/doi.org\/10.1053\/j.gastro.2012.06.007 (2012).","journal-title":"Gastroenterology"},{"key":"10677_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11373-005-9057-3","volume":"13","author":"L Ma","year":"2006","unstructured":"Ma, L., Zhao, X. & Zhu, X. Mitosin\/CENP-F in mitosis, transcriptional control, and differentiation. J. Biomed. Sci. 13, 205\u2013213. https:\/\/doi.org\/10.1007\/s11373-005-9057-3 (2006).","journal-title":"J. Biomed. Sci."},{"key":"10677_CR11","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1242\/jcs.115.17.3403","volume":"115","author":"D Hussein","year":"2002","unstructured":"Hussein, D. & Taylor, S. S. Farnesylation of Cenp-F is required for G2\/M progression and degradation after mitosis. J. Cell. Sci. 115, 3403\u20133414. https:\/\/doi.org\/10.1242\/jcs.115.17.3403 (2002).","journal-title":"J. Cell. Sci."},{"key":"10677_CR12","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.2147\/cmar.S165630","volume":"10","author":"C G\u00f6bel","year":"2018","unstructured":"G\u00f6bel, C. et al. Upregulation of centromere protein F is linked to aggressive prostate cancers. Cancer Manag Res. 10, 5491\u20135504. https:\/\/doi.org\/10.2147\/cmar.S165630 (2018).","journal-title":"Cancer Manag Res."},{"key":"10677_CR13","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.7150\/jca.52187","volume":"12","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. Centromere protein F (CENPF) serves as a potential prognostic biomarker and target for human hepatocellular carcinoma. J. Cancer. 12, 2933\u20132951. https:\/\/doi.org\/10.7150\/jca.52187 (2021).","journal-title":"J. Cancer"},{"key":"10677_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12935-019-0986-8","volume":"19","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer. Cancer Cell. Int. 19, 264. https:\/\/doi.org\/10.1186\/s12935-019-0986-8 (2019).","journal-title":"Cancer Cell. Int."},{"key":"10677_CR15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.7150\/ijms.49041","volume":"18","author":"MX Li","year":"2021","unstructured":"Li, M. X. et al. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Int. J. Med. Sci. 18, 494\u2013504. https:\/\/doi.org\/10.7150\/ijms.49041 (2021).","journal-title":"Int. J. Med. Sci."},{"key":"10677_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12920-020-00800-2","volume":"13","author":"B Yu","year":"2020","unstructured":"Yu, B. et al. TOP2A and CENPF are synergistic master regulators activated in cervical cancer. BMC Med. Genomics. 13, 145. https:\/\/doi.org\/10.1186\/s12920-020-00800-2 (2020).","journal-title":"BMC Med. Genomics"},{"key":"10677_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/cac2.12443","volume":"43","author":"P Xu","year":"2023","unstructured":"Xu, P. et al. N6-methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export. Cancer Commun. (Lond). 43, 685\u2013705. https:\/\/doi.org\/10.1002\/cac2.12443 (2023).","journal-title":"Cancer Commun. (Lond)"},{"key":"10677_CR18","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41598-023-28355-z","volume":"13","author":"D Wang","year":"2023","unstructured":"Wang, D. et al. CENPF knockdown inhibits adriamycin chemoresistance in triple-negative breast cancer via the Rb-E2F1 axis. Sci. Rep. 13, 1803. https:\/\/doi.org\/10.1038\/s41598-023-28355-z (2023).","journal-title":"Sci. Rep."},{"key":"10677_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"10677_CR20","doi-asserted-by":"publisher","unstructured":"Kotolloshi, R., H\u00f6lzer, M., Gajda, M., Grimm, M. O. & Steinbach, D. SLC35F2, a transporter sporadically mutated in the untranslated region, promotes growth, migration, and invasion of bladder Cancer cells. Cells 10, 36.  https:\/\/doi.org\/10.3390\/cells10010080 (2021).","DOI":"10.3390\/cells10010080"},{"key":"10677_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Comprehensive molecular characterization of urothelial bladder carcinoma","year":"2014","unstructured":"Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315\u2013322, doi:https:\/\/doi.org\/10.1038\/nature12965 (2014).","journal-title":"Nature"},{"key":"10677_CR22","doi-asserted-by":"publisher","unstructured":"Shahid, M. et al. Downregulation of CENPF remodels prostate Cancer cells and alters cellular metabolism. Proteomics 19, 752. https:\/\/doi.org\/10.1002\/pmic.201900038 (2019).","DOI":"10.1002\/pmic.201900038"},{"key":"10677_CR23","doi-asserted-by":"publisher","first-page":"e1900038","DOI":"10.1002\/pmic.201900038","volume":"19","author":"M Shahid","year":"2019","unstructured":"Shahid, M. et al. Downregulation of CENPF remodels prostate Cancer cells and alters cellular metabolism. Proteomics 19, e1900038. https:\/\/doi.org\/10.1002\/pmic.201900038 (2019).","journal-title":"Proteomics"},{"key":"10677_CR24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ccr.2014.03.017","volume":"25","author":"A Aytes","year":"2014","unstructured":"Aytes, A. et al. Cross-Species regulatory network analysis identifies a synergistic interaction between and that drives prostate Cancer malignancy. Cancer Cell. 25, 638\u2013651. https:\/\/doi.org\/10.1016\/j.ccr.2014.03.017 (2014).","journal-title":"Cancer Cell."},{"key":"10677_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/abbs\/gmq001","volume":"42","author":"J Du","year":"2010","unstructured":"Du, J., Li, Y. & Zhu, X. Involvement of CENP-F in histone methylation. Acta Biochim. Biophys. Sin. 42, 173\u2013176. https:\/\/doi.org\/10.1093\/abbs\/gmq001 (2010).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10677_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/cm.970260305","volume":"26","author":"JB Rattner","year":"1993","unstructured":"Rattner, J. B., Rao, A., Fritzler, M. J., Valencia, D. W. & Yen, T. J. CENP-F is a.ca 400\u00a0kda kinetochore protein that exhibits a cell-cycle dependent localization. Cell. Motil. Cytoskeleton. 26, 214\u2013226. https:\/\/doi.org\/10.1002\/cm.970260305 (1993).","journal-title":"Cell. Motil. Cytoskeleton"},{"key":"10677_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.bbrc.2013.06.021","volume":"436","author":"Y Dai","year":"2013","unstructured":"Dai, Y. et al. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 436, 711\u2013718. https:\/\/doi.org\/10.1016\/j.bbrc.2013.06.021 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10677_CR28","doi-asserted-by":"publisher","first-page":"21453","DOI":"10.1074\/jbc.M000518200","volume":"275","author":"LM Pab\u00f3n-Pe\u00f1a","year":"2000","unstructured":"Pab\u00f3n-Pe\u00f1a, L. M., Goodwin, R. L., Cise, L. J. & Bader, D. Analysis of CMF1 reveals a bone morphogenetic Protein-independent component of the cardiomyogenic pathway. J. Biol. Chem. 275, 21453\u201321459. https:\/\/doi.org\/10.1074\/jbc.M000518200 (2000).","journal-title":"J. Biol. Chem."},{"key":"10677_CR29","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1128\/mcb.25.10.4062-4074.2005","volume":"25","author":"Z Yang","year":"2005","unstructured":"Yang, Z. et al. Silencing Mitosin induces misaligned chromosomes, premature chromosome decondensation before anaphase onset, and mitotic cell death. Mol. Cell. Biol. 25, 4062\u20134074. https:\/\/doi.org\/10.1128\/mcb.25.10.4062-4074.2005 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"10677_CR30","doi-asserted-by":"publisher","unstructured":"Shi, J., Zhang, P., Liu, L., Min, X. & Xiao, Y. Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer. Mol. Genet. Genom. Med. 7, 96.  https:\/\/doi.org\/10.1002\/mgg3.982 (2019).","DOI":"10.1002\/mgg3.982"},{"key":"10677_CR31","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1038\/sj.emboj.7600848","volume":"24","author":"P Bomont","year":"2005","unstructured":"Bomont, P., Maddox, P., Shah, J. V., Desai, A. B. & Cleveland, D. W. Unstable microtubule capture at kinetochores depleted of the centromere-associated protein CENP-F. EMBO J. 24, 3927\u20133939. https:\/\/doi.org\/10.1038\/sj.emboj.7600848 (2005).","journal-title":"EMBO J."},{"key":"10677_CR32","doi-asserted-by":"publisher","unstructured":"Mokhosoev, I. M., Astakhov, D. V., Terentiev, A. A. & Moldogazieva, N. T. Human cytochrome P450 Cancer-Related metabolic activities and gene polymorphisms: a review. Cells 13, 123. https:\/\/doi.org\/10.3390\/cells13231958 (2024).","DOI":"10.3390\/cells13231958"},{"key":"10677_CR33","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1089\/cmb.2019.0237","volume":"27","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Analysis of gene expression in bladder cancer: possible involvement of mitosis and complement and coagulation cascades signaling pathway. J. Comput. Biol. 27, 987\u2013998. https:\/\/doi.org\/10.1089\/cmb.2019.0237 (2020).","journal-title":"J. Comput. Biol."},{"key":"10677_CR34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/cvr\/cvy023","volume":"114","author":"RM Touyz","year":"2018","unstructured":"Touyz, R. M. et al. Vascular smooth muscle contraction in hypertension. Cardiovasc. Res. 114, 529\u2013539. https:\/\/doi.org\/10.1093\/cvr\/cvy023 (2018).","journal-title":"Cardiovasc. Res."},{"key":"10677_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/bs.ircmb.2019.03.002","volume":"346","author":"L Rosan\u00f2","year":"2019","unstructured":"Rosan\u00f2, L. & Bagnato, A. New insights into the regulation of the actin cytoskeleton dynamics by GPCR\/\u03b2-arrestin in cancer invasion and metastasis. Int. Rev. Cell. Mol. Biol. 346, 129\u2013155. https:\/\/doi.org\/10.1016\/bs.ircmb.2019.03.002 (2019).","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"10677_CR36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-cellbio-111315-125341","volume":"32","author":"EK Paluch","year":"2016","unstructured":"Paluch, E. K., Aspalter, I. M. & Sixt, M. Focal Adhesion-Independent cell migration. Annu. Rev. Cell. Dev. Biol. 32, 469\u2013490. https:\/\/doi.org\/10.1146\/annurev-cellbio-111315-125341 (2016).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"10677_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/bioinformatics\/btx689","volume":"34","author":"L Sanchez-Pulido","year":"2018","unstructured":"Sanchez-Pulido, L. & Ponting, C. P. TMEM132: an ancient architecture of cohesin and Immunoglobulin domains define a new family of neural adhesion molecules. Bioinformatics 34, 721\u2013724. https:\/\/doi.org\/10.1093\/bioinformatics\/btx689 (2018).","journal-title":"Bioinformatics"},{"key":"10677_CR38","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.7150\/jca.96396","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang, M. et al. Multidimensional analysis of TMEM132A in pan-cancer: unveiling its potential as a biomarker for treatment response prediction. J. Cancer. 15, 4386\u20134405. https:\/\/doi.org\/10.7150\/jca.96396 (2024).","journal-title":"J. Cancer"},{"key":"10677_CR39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.31083\/j.fbl2910360","volume":"29","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Study of the role of E2F1 and TMEM132A in prostate Cancer development. Front. Biosci. (Landmark Ed). 29, 360. https:\/\/doi.org\/10.31083\/j.fbl2910360 (2024).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10677_CR40","doi-asserted-by":"publisher","unstructured":"Rold\u00e1n, F. L. et al. Prognostic gene Expression-Based signature in Clear-Cell renal cell carcinoma. Cancers (Basel). 14, 253. https:\/\/doi.org\/10.3390\/cancers14153754 (2022).","DOI":"10.3390\/cancers14153754"},{"key":"10677_CR41","doi-asserted-by":"publisher","first-page":"599890","DOI":"10.3389\/fcell.2020.599890","volume":"8","author":"B Li","year":"2020","unstructured":"Li, B. & Niswander, L. A. TMEM132A, a novel Wnt signaling pathway regulator through Wntless (WLS) interaction. Front. Cell. Dev. Biol. 8, 599890. https:\/\/doi.org\/10.3389\/fcell.2020.599890 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"10677_CR42","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ijbiomac.2015.08.016","volume":"81","author":"R Liu","year":"2015","unstructured":"Liu, R. et al. Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1. Int. J. Biol. Macromol. 81, 491\u2013497. https:\/\/doi.org\/10.1016\/j.ijbiomac.2015.08.016 (2015).","journal-title":"Int. J. Biol. Macromol."},{"key":"10677_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1049\/syb2.12011","volume":"15","author":"ZG Huang","year":"2021","unstructured":"Huang, Z. G. et al. MiRNA-145-5p expression and prospective molecular mechanisms in the metastasis of prostate cancer. IET Syst. Biol. 15, 1\u201313. https:\/\/doi.org\/10.1049\/syb2.12011 (2021).","journal-title":"IET Syst. Biol."},{"key":"10677_CR44","doi-asserted-by":"publisher","first-page":"e662","DOI":"10.1097\/cad.0000000000001231","volume":"33","author":"D Xu","year":"2022","unstructured":"Xu, D., Jiang, J., He, G., Zhou, H. & Ji, C. miR-143-3p represses leukemia cell proliferation by inhibiting KAT6A expression. Anticancer Drugs 33, e662\u2013e669. https:\/\/doi.org\/10.1097\/cad.0000000000001231 (2022).","journal-title":"Anticancer Drugs"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10677-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10677-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10677-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T17:14:38Z","timestamp":1752513278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10677-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10677"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10677-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. This paper does not engage in animal experimentation or involve any animal ethics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"25398"}}